We previously also showed that active targeting to PSMA enhances tumor uptake of intact PSMA-NBs with extended retention, which results in the prolonged US signal enhancement in the tumors that can be visualized with clinical nonlinear ultrasound 4. This evidence concerns the gene FOLH1 and neoplasm.